Literature DB >> 8463992

Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis.

G M Devins1, S M Edworthy, L C Paul, H Mandin, T P Seland, G Klein, C G Costello, C M Shapiro.   

Abstract

Restless sleep was compared across 110 out-patients with rheumatoid arthritis (RA), 101 with end-stage renal disease (ESRD), 94 with multiple sclerosis (MS), and an unselected control group of 176 individuals attending their family practitioners (FP). It was also investigated in the three chronic illness groups as a contributor to illness intrusiveness--the extent to which one's illness and/or its treatment interfere with continued involvements in valued activities and interests--a determinant of depression and emotional distress in chronic conditions. Reported frequencies of restless sleep were highest in RA, lower in ESRD, and lowest in MS; FP patients reported frequencies that were similar, overall, to those observed in MS. These differences were evident among nondepressed, (chi 2 9, N = 309, p < 0.0001), but not depressed, individuals. The occurrence of restless sleep correlated significantly with increased illness intrusiveness, r (279) = 0.31, p < 0.001, in RA, ESRD, and MS. Results supported the hypothesis that the relation between restless sleep and emotional distress is mediated by illness intrusiveness. Treatment of restless sleep may offer the added benefit of diminishing illness intrusiveness and may, thereby, enhance quality of life in chronic physical illness.

Entities:  

Mesh:

Year:  1993        PMID: 8463992     DOI: 10.1016/0022-3999(93)90083-r

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  19 in total

Review 1.  Impact of insomnia on health-related quality of life.

Authors:  C Idzikowski
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

2.  The Illness Intrusiveness Rating Scale: a measure of severity in individuals with hyperhidrosis.

Authors:  C S Cinà; C M Clase
Journal:  Qual Life Res       Date:  1999-12       Impact factor: 4.147

Review 3.  Drug-induced sleep disturbances. Focus on nonpsychotropic medications.

Authors:  M Novak; C M Shapiro
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

4.  Sleep disturbances in pediatric dialysis patients.

Authors:  Ira D Davis; Joshua Baron; Mary Ann O'riordan; Carol L Rosen
Journal:  Pediatr Nephrol       Date:  2004-11-24       Impact factor: 3.714

5.  Factor structure of the Korean version of illness intrusiveness rating scale: cross-cultural implications.

Authors:  Daeho Kim; Kwang-iel Kim; Haewon Lee; Joonho Choi; Yong-Chon Park
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

6.  The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study.

Authors:  Thomas Roth; Janet M Price; David A Amato; Robert P Rubens; James M Roach; Thomas J Schnitzer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 7.  The prevalence, cost implications, and management of sleep disorders: an overview.

Authors:  Jamil L Hossain; Colin M Shapiro
Journal:  Sleep Breath       Date:  2002-06       Impact factor: 2.816

Review 8.  Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation.

Authors:  Jerusha B Detweiler-Bedell; Michael A Friedman; Howard Leventhal; Ivan W Miller; Elaine A Leventhal
Journal:  Clin Psychol Rev       Date:  2008-09-09

9.  Illness intrusiveness and subjective well-being in patients with glioblastoma.

Authors:  Kim Edelstein; Linda Coate; Christine Massey; Natalie C Jewitt; Warren P Mason; Gerald M Devins
Journal:  J Neurooncol       Date:  2015-09-29       Impact factor: 4.130

10.  Failure of physician documentation of sleep complaints in hospitalized patients.

Authors:  H H Meissner; A Riemer; S M Santiago; M Stein; M D Goldman; A J Williams
Journal:  West J Med       Date:  1998-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.